Precision Surgical Therapy for Adenocarcinoma of the Esophagus and Esophagogastric Junction.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published Date:

Abstract

INTRODUCTION: To facilitate the initial clinical decision regarding whether to use esophagectomy alone or neoadjuvant therapy in surgical care for individual patients with adenocarcinoma of the esophagus and esophagogastric junction-information not available from randomized trials-a machine-learning analysis was performed using worldwide real-world data on patients undergoing different therapies for this rare adenocarcinoma.

Authors

  • Thomas W Rice
    Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio.
  • Min Lu
    Hangzhou Science and Technology Information Institute, Hangzhou, Zhejiang, China.
  • Hemant Ishwaran
    Division of Biostatistics, University of Miami.
  • Eugene H Blackstone
    Department of Heart and Vascular Institute, Cleveland Clinic.